John Lippincott

John "Lippy" Lippincott is a seasoned biotechnology professional currently serving as Senior Vice President of Therapeutic Discovery Strategies at Alloy Therapeutics, Inc., since April 2023. Lippincott has extensive experience in therapeutic discovery, having held prominent roles such as Senior Vice President at AlivaMab Discovery Services and Vice President of Research at AlivaMab. Previous positions include Director of Research Operations at Ablexis, LLC, Vice President of Antibody Discovery at LakePharma, and Director of Antibody Discovery at Igenica. Lippincott began a career in research at Pfizer as a Senior Principal Scientist and completed a postdoctoral fellowship at GNF. Educational qualifications include a Ph.D. in Cell Biology from Harvard Medical School and dual Bachelor's degrees in Microbiology and Biochemistry from the University of Washington.